Fortive Corp. (F03.DE)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 4,634 | 5,255 | 5,826 | 6,065 | 6,232 | 4,159 | 3,751 | 4,299 |
| Operating profit | $m | 720 | 839 | ||||||
| Net profit | $m | 1,383 | 580 | 755 | 866 | 833 | 579 | 543 | 994 |
| EPS reported | $ | 1.73 | 1.67 | ||||||
| Operating cashflow per share | $ | 3.26 | 3.48 | ||||||
| Capex per share | $ | 0.32 | 0.34 | ||||||
| FCF per share | $ | 2.95 | 3.14 | ||||||
| Free cash flow | $m | 978 | 945 | ||||||
| Net debt | $m | 2,757 | 3,121 | ||||||
| Book value equity | $m | 6,454 | 6,060 | ||||||
| Book value per share | $ | 19.29 | 19.37 | ||||||
| Number of shares | m | 334.6 | 312.8 | ||||||
| DPS (TTM paid) | $ | 0.28 | 0.31 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 32.18 | 34.35 | ||||||
| P/B LTM | x | 2.86 | 3.05 | ||||||
| P/S LTM | x | 4.44 | 4.93 | ||||||
| P/FCF LTM | x | 18.90 | 19.57 | ||||||
| EV/EBITDA LTM | x | 18.37 | 19.45 | ||||||
| EV/Sales LTM | x | 5.12 | 4.54 | ||||||
| Earnings Yield LTM | % | +3.11% | +2.91% | ||||||
| FCF Yield | % | +5.29% | +5.11% | ||||||
| Quality | |||||||||
| ROE | % | +8.98% | +7.39% | ||||||
| ROIC | % | +6.12% | +7.29% | ||||||
| Operating margin | % | +17.32% | +17.73% | ||||||
| Gross margin | % | +63.50% | +61.83% | ||||||
| FCF/Sales | % | +23.52% | +20.50% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -26.69% | -29.24% | ||||||
| Sales Growth YoY | % | -33.26% | -39.82% | ||||||
| Net Income Growth YoY | % | -30.46% | -34.78% | ||||||
| FCF Growth | % | -30.45% | -32.83% | ||||||
| Operating Profit Growth | % | -40.31% | -30.44% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +0.50% | +0.40% | ||||||
| Dividend Growth | % | -12.03% | -2.61% | ||||||
| Payout Ratio | % | +15.93% | +15.27% | ||||||
| FCF/Debt | x | 0.31 | 0.27 | ||||||
| Net Debt/EBITDA | x | 2.44 | 2.56 | ||||||
| EBIT/Net interest | x | 5.98 | 6.99 | ||||||
| Net debt/market cap | % | +17.49% | +19.00% | ||||||
| Net debt/Equity | x | 0.43 | 0.52 | ||||||
| Gross debt/equity | x | 0.50 | 0.57 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded by James A. Lico and Stacey A. Walker on November 10, 2015 and is headquartered in Everett, WA.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded by James A. Lico and Stacey A. Walker on November 10, 2015 and is headquartered in Everett, WA.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free